| David T Tullis, MD | |
|
1000 N Main St, Richfield, UT 84701-1857 | |
| (435) 896-8271 | |
| Not Available |
| Full Name | David T Tullis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 1000 N Main St, Richfield, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548340714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 59809631205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Rates of cardiovascular disease increase dramatically in Australian winters because many people don't know how to rug up against the cold, a Queensland University of Technology seasonal researcher has found.
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Colliers International today announced the results of its 2015 Medical Office Outlook Report, which points to the trend of "retailization" of healthcare as a key driver behind increased demand for healthcare real estate.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Rates of cardiovascular disease increase dramatically in Australian winters because many people don't know how to rug up against the cold, a Queensland University of Technology seasonal researcher has found.
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Colliers International today announced the results of its 2015 Medical Office Outlook Report, which points to the trend of "retailization" of healthcare as a key driver behind increased demand for healthcare real estate.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Rates of cardiovascular disease increase dramatically in Australian winters because many people don't know how to rug up against the cold, a Queensland University of Technology seasonal researcher has found.
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Colliers International today announced the results of its 2015 Medical Office Outlook Report, which points to the trend of "retailization" of healthcare as a key driver behind increased demand for healthcare real estate.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David T Tullis, MD Po Box 30180, Salt Lake City, UT 84130-0180 Ph: (801) 357-7475 | David T Tullis, MD 1000 N Main St, Richfield, UT 84701-1857 Ph: (435) 896-8271 |
News Archive
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Rates of cardiovascular disease increase dramatically in Australian winters because many people don't know how to rug up against the cold, a Queensland University of Technology seasonal researcher has found.
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Colliers International today announced the results of its 2015 Medical Office Outlook Report, which points to the trend of "retailization" of healthcare as a key driver behind increased demand for healthcare real estate.
› Verified 8 days ago
Colten Dirk Bracken, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Main St, Richfield, UT 84701 Phone: 435-893-4100 | |
Mark Robert Greenwood, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 460 N Main St, Richfield, UT 84701 Phone: 435-896-5496 | |
Mark W Greenwood, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 460 N Main St, Richfield, UT 84701 Phone: 435-896-5496 | |
Jeffrey J Brown, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 70 E 1100 N, Richfield, UT 84701 Phone: 435-896-8254 | |
David R Crimin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 E 1100 N, Richfield, UT 84701 Phone: 435-893-0580 | |
Steven James Jones, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Main St, Richfield, UT 84701 Phone: 435-893-0580 | |
David M Pope, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1000 N Main St, Richfield, UT 84701 Phone: 435-893-4100 |